NuggMD, the Nation’s Leading Online Telemedicine Platform for Medical Cannabis Patients and Physicians, Expands Its Services to Missouri

KANSAS CITY, Mo., Jan. 6, 2020 /PRNewswire/ — On Jan. 6, 2020, NuggMD, the California-based industry-leading telemedicine platform that connects medical marijuana patients with state-licensed physicians, has announced that they’re extending their services to Missouri. NuggMD is committed to expanding access for patients who need cannabis, and to combating policies and prejudices that restrict access to medical marijuana despite overwhelming support for legalization.

As of 2020, NuggMD has helped more than half a million patients obtain their medical marijuana evaluations entirely online with fully-licensed physicians in good standing with their state. They are thrilled to add Missouri physicians to their platform to provide efficient and compassionate care to patients statewide.

In November 2018, Missouri voters passed Amendment 2 by a 66% majority, allowing medical doctors and osteopaths to provide medical marijuana recommendations to patients with a qualifying medical condition. Amendment 2 has built-in protections for physicians who are willing to certify patients for cannabis treatment, but many physicians are still unwilling to discuss this option with their patients due to cannabis’s status as a Schedule 1 Drug.

The founders and physicians of NuggMD believe that every Missouri resident deserves the option to use medical marijuana if it can help to relieve their suffering or combat addictions to potentially harmful prescription medications. 

“The FDA and medical establishments are clearly dragging their feet at this point,” says NuggMD founder and CMO Alex Milligan. “The people have spoken in resounding voices, demanding access to cannabis to alleviate suffering. But cannabis is still a Schedule 1 Drug despite the obvious fact that it’s helping millions to treat painkiller addiction, epilepsy, PTSD, and many other disorders. Medical marijuana is legal in 33 states now, and recreational marijuana is legal in 11 states. It’s time for the federal government to admit that cannabis doesn’t belong on the Schedule 1 list, and it never did.”

Due to the very liberal list of qualifying conditions in Missouri, the number of marijuana patients in the state is growing at a much more rapid rate than predicted. As of December 2019, more than 22,000 patients had registered with the program despite the fact that dispensaries haven’t even opened yet.

NuggMD’s founders believe that registration with the program will soon approach the astonishing levels seen in Oklahoma, where roughly 4% of the population became registered patients in only a year. “It wouldn’t surprise me to see nearly 3% of Missouri’s population sign up for medical marijuana patient IDs by this time next year,” says NuggMD founder and COO Kam Babazade. “The population wanted a liberal qualifying conditions list for a reason – because they want this decision to be up to physicians, not legislators. That’s why Amendment 2 won over the other two more conservative measures by a considerable margin. There are thousands of patients who are left behind in other states because their conditions are rare or less common. Don’t these patients deserve the same protections? Missouri made the right choice.”

The cost for a medical marijuana evaluation with a state-licensed NuggMD physician is just $139 in Missouri, $99 in Oklahoma, $149 in New York, $79 in Nevada, and $49 in California. All NuggMD physicians are fully-licensed and in good standing in the state for which they offer medical marijuana evaluations.

About NuggMD

NuggMD is the nation’s leading medical marijuana technology platform, facilitating access to medical marijuana for patients in New York, California, Nevada, Oklahoma and Missouri. NuggMD’s patients receive their evaluations entirely online via face-to-face video chats from the comfort and privacy of their own home. Qualifying medical conditions vary by state. Since their launch in 2016, NuggMD has helped more than half a million medical marijuana patients connect with their new physicians and obtain their medical marijuana recommendations. They are fully committed to improving their patients’ quality of life through cannabis.

For further information, visit nuggmd.com/missouri

Contact:

Alex Milligan
Co-founder & CMO
alex@getnugg.com

View original content:http://www.prnewswire.com/news-releases/nuggmd-the-nations-leading-online-telemedicine-platform-for-medical-cannabis-patients-and-physicians-expands-its-services-to-missouri-300981887.html

SOURCE NuggMD

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

17 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

17 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

2 days ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

2 days ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

2 days ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

2 days ago